| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangement
|
Nesteryuk, Vasyl
|
|
|
|
8 |
p. e550-e555
|
artikel
|
| 2 |
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases
|
Itchins, Malinda
|
|
|
|
8 |
p. 702-708
|
artikel
|
| 3 |
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)
|
Kim, Kyung Hwan
|
|
|
|
8 |
p. e536-e539
|
artikel
|
| 4 |
An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans
|
Li, Shaolei
|
|
|
|
8 |
p. e301-e310
|
artikel
|
| 5 |
A Phase IB Trial of Autologous Cytokine‐Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death‐1, plus Chemotherapy in Patients with Advanced Non‐Small‐Cell Lung Cancer
|
Zhou, Li
|
|
|
|
8 |
p. 709-719
|
artikel
|
| 6 |
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations
|
Ahn, Myung-Ju
|
|
|
|
8 |
p. 670-685
|
artikel
|
| 7 |
Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung Cancer
|
Shah, Mohsin
|
|
|
|
8 |
p. 731-736
|
artikel
|
| 8 |
Brief Report: First-line Pembrolizumab in Metastatic Non-Small Cell Lung Cancer Habouring MET Exon 14 Skipping Mutation and PD-L1 ≥50% (GFPC 01-20 Study)
|
Guisier, Florian
|
|
|
|
8 |
p. e545-e549
|
artikel
|
| 9 |
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer
|
Yu, Nathan Y.
|
|
|
|
8 |
p. e526-e535
|
artikel
|
| 10 |
CCND1 Messenger RNA Expression Is Correlated with EGFR Mutation Status in Lung Cancer
|
Sasaki, Hidefumi
|
|
2007
|
|
8 |
p. 493-496
4 p.
|
artikel
|
| 11 |
Combination Intravenous Immune Globulin (IVIG) and High Dose Steroids for Treatment of Immune-Related Myelitis in a Non-Small Cell Lung Cancer Patient Treated With Pembrolizumab and Palliative Radiation Treatment: A Case Report
|
Owen, Timothy
|
|
|
|
8 |
p. e563-e567
|
artikel
|
| 12 |
Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
|
Banks, Kian C.
|
|
|
|
8 |
p. 694-701
|
artikel
|
| 13 |
CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months
|
Brown, William T.
|
|
2007
|
|
8 |
p. 488-492
5 p.
|
artikel
|
| 14 |
Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers
|
Huang, Bao-Tian
|
|
|
|
8 |
p. e323-e331.e2
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
|
8 |
p. A1
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
|
8 |
p. A2
|
artikel
|
| 17 |
Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the “PACIFIC” Era
|
Adachi, Hiroyuki
|
|
|
|
8 |
p. 733-742
|
artikel
|
| 18 |
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
|
Ahn, Myung J.
|
|
|
|
8 |
p. 720-730
|
artikel
|
| 19 |
Efficacy of Tyrosine Kinase Inhibitors in Primary Driver-Gene-Positive Combined Small-Cell Lung Cancer: A Retrospective Study
|
Shi, Zheng
|
|
|
|
8 |
p. 717-725.e1
|
artikel
|
| 20 |
2007 Highlights from: the 43rd Annual Meeting of the American Society of Clinical Oncology Chicago, IL; June 2007
|
Ranganathan, Aarati
|
|
2007
|
|
8 |
p. 468-475
8 p.
|
artikel
|
| 21 |
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events
|
Guo, Mengni
|
|
|
|
8 |
p. 686-693
|
artikel
|
| 22 |
Immunotherapy in Advanced NSCLC Without Driver Mutations: Available Therapeutic Alternatives After Progression and Future Treatment Options
|
Leal, Jose Luis
|
|
|
|
8 |
p. 643-658
|
artikel
|
| 23 |
Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in Patients Receiving Immune Checkpoint Inhibitors for Non–Small-Cell Lung Cancer
|
Petranovic, Milena
|
|
|
|
8 |
p. 682-688.e5
|
artikel
|
| 24 |
Incidence of Pneumonitis Among Limited Stage Small Cell Lung Cancer Patients Exposed to Concurrent Chemoradiation: A Systematic Literature Review and Meta-Analysis
|
Kuang, Yuting
|
|
|
|
8 |
p. 659-669
|
artikel
|
| 25 |
Intraoperative Versus Preoperative Diagnosis of Lung Cancer: Differences in Treatments and Patient Outcomes
|
Mack, Shale J.
|
|
|
|
8 |
p. 726-732
|
artikel
|
| 26 |
Machine-Learning-Aided Prediction of Brain Metastases Development in Non–Small-Cell Lung Cancers
|
Visonà, Giovanni
|
|
|
|
8 |
p. e311-e322
|
artikel
|
| 27 |
Malignant Primary Pulmonary Tumor with Hemangiopericytoma-Like Features: Conventional Hemangiopericytoma Versus Solitary Fibrous Tumor
|
Radulescu, Dan
|
|
2007
|
|
8 |
p. 504-508
5 p.
|
artikel
|
| 28 |
Outcome of Incidental Pulmonary Nodules in a Real-World Setting
|
Vindum, Helene Hjorth
|
|
|
|
8 |
p. 673-681
|
artikel
|
| 29 |
Outcomes of Intraocular Metastasis From Lung Cancer in the Era of Targeted Therapy: A Systematic Review and Pooled Analysis
|
Maller, Bradley
|
|
|
|
8 |
p. e519-e525
|
artikel
|
| 30 |
Paclitaxel/Carboplatin/Gemcitabine Versus Gemcitabine/Vinorelbine in Advanced Non–Small-Cell Lung Cancer: A Phase II/III Study of the Minnie Pearl Cancer Research Network
|
Greco, F. Anthony
|
|
2007
|
|
8 |
p. 483-487
5 p.
|
artikel
|
| 31 |
Patient Demographics in HOG LUN 01-24 Versus SWOG 9504: Apples Versus Oranges?
|
Gaspar, Laurie E.
|
|
2007
|
|
8 |
p. 466-467
2 p.
|
artikel
|
| 32 |
PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study
|
Faria, Nuno
|
|
|
|
8 |
p. 753-760
|
artikel
|
| 33 |
Phase II Pharmacogenomics-Based Adjuvant Therapy Trial in Patients with Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial 0720
|
Bepler, Gerold
|
|
2007
|
|
8 |
p. 509-511
3 p.
|
artikel
|
| 34 |
Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report
|
Wang, Pascal
|
|
|
|
8 |
p. e568-e572
|
artikel
|
| 35 |
Predictors of Secondary Lung Cancer Among Hodgkin Lymphoma Survivors: A Nationwide Analysis
|
Alnimer, Yanal
|
|
|
|
8 |
p. e510-e518
|
artikel
|
| 36 |
Prognostication Using the Japanese Risk Calculator for Lung Cancer Surgery
|
Ozawa, Hiroki
|
|
|
|
8 |
p. 743-752.e2
|
artikel
|
| 37 |
Prognostic Factors in Stage III Non–Small-Cell Lung Cancer
|
Ademuyiwa, Foluso O.
|
|
2007
|
|
8 |
p. 478-482
5 p.
|
artikel
|
| 38 |
Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non–Small-Cell Lung Cancer
|
Eichhorn, Florian
|
|
|
|
8 |
p. 706-716.e1
|
artikel
|
| 39 |
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer
|
Desai, Aakash
|
|
|
|
8 |
p. 689-695.e1
|
artikel
|
| 40 |
Relief from Sleep Apnea After Radiation and Chemotherapy
|
Ursavaş, Ahmet
|
|
2007
|
|
8 |
p. 502-503
2 p.
|
artikel
|
| 41 |
Safety of Irinotecan/Cisplatin Versus Etoposide/Cisplatin for Patients with Extensive-Stage Small-Cell Lung Cancer: A Metaanalysis
|
Jiang, Lei
|
|
2007
|
|
8 |
p. 497-501
5 p.
|
artikel
|
| 42 |
Table of Contents
|
|
|
|
|
8 |
p. A3-A6
|
artikel
|
| 43 |
Table of Contents
|
|
|
|
|
8 |
p. A3-A5
|
artikel
|
| 44 |
Targeted therapy for lung cancer with paraneoplastic disseminated intravascular coagulation: A case report and pooled analysis
|
Pevner, Justin L.
|
|
|
|
8 |
p. e540-e544
|
artikel
|
| 45 |
The Effect of Intrathoracic Lesion Location on Initial Tyrosine Kinase Inhibitor Response in Advanced Oncogene-Addicted Non-Small Cell Lung Cancer: A Comparison Between RECIST 1.1 and a Novel Method of Response Assessment (MAX)
|
Bang, Tami J.
|
|
|
|
8 |
p. e501-e509
|
artikel
|
| 46 |
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series
|
Gross, Andrew J.
|
|
|
|
8 |
p. 696-705
|
artikel
|
| 47 |
U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome
|
Kaland, David A.
|
|
|
|
8 |
p. e556-e562
|
artikel
|
Tijdschrift beschrijving